Stay updated on Pembrolizumab in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.
Latest updates to the Pembrolizumab in HCC Clinical Trial page
- ChecktodayChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.3%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check36 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check52 days agoChange DetectedThe website has added new features for user interaction, while several detailed data fields and options for downloading study information have been removed.SummaryDifference4%
- Check59 days agoChange DetectedSeveral key health-related websites, including Dailymed and various government health resources, have been removed from the monitored list.SummaryDifference0.4%
- Check66 days agoChange DetectedThe website has been updated to Revision v2.12.2, with new additions including links to clinical trial resources and data fields for downloading study information.SummaryDifference5%
Stay in the know with updates to Pembrolizumab in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.